Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

bio-enhanced curcumin extract formulation

A bio-enhanced extract-based preparation containing curcumin, a poorly water-soluble phytopolylphenol pigment isolated from the plant Curcuma longa, commonly known as turmeric, with a variety of pharmacologic properties, including antineoplastic, chemopreventive, antioxidant, anti-angiogenic, neuroprotective and anti-inflammatory activities. Upon oral administration, curcumin blocks the formation of reactive-oxygen species, neutralizes free radicals, and prevents oxidative stress and DNA damage. Curcumin also possesses anti-inflammatory properties as a result of inhibition of cyclooxygenases (COX) and other enzymes involved in inflammation. It disrupts various cell signal transduction pathways involved in carcinogenesis and prevents the expression of many transcription factors. In addition, curcumin modulates phase II enzymes. Altogether, this prevents and/or inhibits tumor cell formation and proliferation. Compared to the very poorly absorbed curcumin alone, this extract formulation, by micronizing curcumin and adding turmeric essential oils, has a much greater bioavailability, an improved pharmacokinetic profile and increased efficacy.
Synonym:BCM-95 (R) CG
BCM-95 CG curcumin
BCM-95 CG curcumin extract
bio-enhanced BCM-95 CG curcumin
curcumin BCM-95CG
US brand name:Biocurcumax
Code name:BCM-95CG
BCM95 CG
BCM95CG
Search NCI's Drug Dictionary